Subcutaneous Nodules during Treatment with an Exenatide Long-Actin Once-Weekly Formulation: An Ultrasound Evaluation
TNFα inhibitors and glucagon-like peptide-1 receptor agonists (GLP1-Ras) including exenatide and its longacting once-weekly formulation (EQW) as already reported in specific registration studies. Accordingly, this…

